Pegs for Osteofixation of Proximal Humeral Fractures

Sponsor
Oslo University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04622852
Collaborator
(none)
38
1
49
0.8

Study Details

Study Description

Brief Summary

Patients treated operative for Proximal humeral fractures with angular stable device (Philos plate or ALPS-PHP)

Condition or Disease Intervention/Treatment Phase
  • Device: Open reduction internal fixation (ORIF) with an angular stable plate

Detailed Description

From a cohort of patients treated for displaced Proximal humeral fractures (PHF) in the period July 2017 - August 2019 patients with the 11-B2 and 11-C2 PHF according to AO/OTA 2007 fracture classification were selected according to age and gender to be compared with patients operated with a Philos plate within the same fracture group, age and gender to be matched for adverse events:

  1. Radiographic evidence of penetration of pegs (ALPS-PHP) or screws (Philos) into the glenohumeral joint (primary outcome) and

  2. Avascular head necrosis / sinking / need of re-surgery

  3. Clinical PROMS

Study Design

Study Type:
Observational
Actual Enrollment :
38 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Are Pegs Better Than Screw for Osteofixation of Proximal Humeral Fractures?
Actual Study Start Date :
Jul 1, 2017
Actual Primary Completion Date :
Sep 1, 2020
Actual Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Group A: ALPS-PHP device

Patients operated with angular stable plate for displaced PHF with an ALPS plate

Device: Open reduction internal fixation (ORIF) with an angular stable plate
Operative treatment of proximal humeral fracture

Group B: Philos device

Patients operated with angular stable plate for displaced PHF with a Philos plate

Device: Open reduction internal fixation (ORIF) with an angular stable plate
Operative treatment of proximal humeral fracture

Outcome Measures

Primary Outcome Measures

  1. Peg penetration into glenohumeral joint [12 months]

    Radiographic or CT verified peg penetration

  2. Screw penetration into glenohumeral joint [12 months]

    Radiographic or CT verified screw penetration

Secondary Outcome Measures

  1. Humeral head deformation [12 months]

    Avascular head necrosis or Sinking

  2. Shoulder function [12 months]

    Constant-Murley score

  3. Self reported shoulder function [12 months]

    Oxford scoulder score

  4. Quality of life [12 months]

    Generic 15D score

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criterion:
  • Acute proximal humeral fracture

  • AO/OTA type 11-B2 or 11C2

Exclusion Criteria:
  • Not eligible to surgical treatment

  • Non-compliant

  • Former shoulder fracture or symptomatic shoulder illness

  • Drug abuser

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oslo University Hospital Oslo Norway

Sponsors and Collaborators

  • Oslo University Hospital

Investigators

  • Principal Investigator: Tore Fjalestad, MD, PhD., Oslo University Hospital, Ortophaedic Dept.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tore Fjalestad, MD. PhD. Senior Consultant Ortophaedic Surgeon, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT04622852
Other Study ID Numbers:
  • 2017/681
First Posted:
Nov 10, 2020
Last Update Posted:
Sep 14, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tore Fjalestad, MD. PhD. Senior Consultant Ortophaedic Surgeon, Oslo University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2021